These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6640552

  • 1. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.
    Chaplinski T, Laszlo J, Moore J, Silverman P.
    Cancer Treat Rep; 1983 Nov; 67(11):1009-12. PubMed ID: 6640552
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum.
    Figlin RA, Callaghan M, Sarna G.
    Cancer Treat Rep; 1983 May; 67(5):493-4. PubMed ID: 6850664
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
    Vugrin D, Hood L, Taylor W, Laszlo J.
    Cancer Treat Rep; 1985 May; 69(7-8):817-20. PubMed ID: 4016792
    [Abstract] [Full Text] [Related]

  • 4. Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.
    Sarna G, Figlin R, Callaghan M.
    J Biol Response Mod; 1983 May; 2(4):343-7. PubMed ID: 6315898
    [Abstract] [Full Text] [Related]

  • 5. Phase II trial of high-dose recombinant leukocyte alpha-2 interferon for metastatic colorectal cancer without previous systemic treatment.
    Eggermont AM, Weimar W, Marquet RL, Laméris JD, Jeekel J.
    Cancer Treat Rep; 1985 Feb; 69(2):185-7. PubMed ID: 3882227
    [Abstract] [Full Text] [Related]

  • 6. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
    Furue H.
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
    [Abstract] [Full Text] [Related]

  • 7. Phase II trial of recombinant beta interferon in advanced colorectal cancer.
    Lillis PK, Brown TD, Beougher K, Koeller J, Marcus SG, Von Hoff DD.
    Cancer Treat Rep; 1987 Oct; 71(10):965-7. PubMed ID: 3308080
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial.
    Krown SE, Burk MW, Kirkwood JM, Kerr D, Morton DL, Oettgen HF.
    Cancer Treat Rep; 1984 May; 68(5):723-6. PubMed ID: 6722830
    [Abstract] [Full Text] [Related]

  • 17. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 May; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 18. Open-label phase II trial of recombinant beta interferon (IFN-beta (ser)) in patients with colorectal cancer.
    Triozzi PL, Kenney P, Young D, Rinehart JJ.
    Cancer Treat Rep; 1987 Oct; 71(10):983-4. PubMed ID: 3308083
    [No Abstract] [Full Text] [Related]

  • 19. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K.
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
    [Abstract] [Full Text] [Related]

  • 20. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.